DI IANNI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 4.616
AS - Asia 3.352
EU - Europa 2.432
SA - Sud America 374
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 10.847
Nazione #
US - Stati Uniti d'America 4.508
SG - Singapore 1.602
CN - Cina 870
IT - Italia 560
IE - Irlanda 360
RU - Federazione Russa 360
SE - Svezia 359
BR - Brasile 312
VN - Vietnam 309
TR - Turchia 280
UA - Ucraina 243
DE - Germania 162
GB - Regno Unito 116
HK - Hong Kong 67
FR - Francia 61
IN - India 56
CA - Canada 52
MX - Messico 45
FI - Finlandia 34
NL - Olanda 34
PL - Polonia 26
BD - Bangladesh 25
AR - Argentina 22
JP - Giappone 22
ES - Italia 21
ZA - Sudafrica 20
AT - Austria 16
BE - Belgio 16
IQ - Iraq 15
GR - Grecia 13
KR - Corea 12
PK - Pakistan 12
CO - Colombia 10
UZ - Uzbekistan 10
RO - Romania 9
VE - Venezuela 9
EG - Egitto 8
ID - Indonesia 8
MA - Marocco 8
PH - Filippine 8
CH - Svizzera 7
EC - Ecuador 7
MY - Malesia 7
CL - Cile 6
CZ - Repubblica Ceca 6
EU - Europa 6
SA - Arabia Saudita 6
AL - Albania 5
JO - Giordania 5
KE - Kenya 5
LT - Lituania 5
TH - Thailandia 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
AU - Australia 3
BO - Bolivia 3
BW - Botswana 3
JM - Giamaica 3
KZ - Kazakistan 3
NP - Nepal 3
PE - Perù 3
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
KH - Cambogia 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
SN - Senegal 1
Totale 10.845
Città #
Singapore 1.249
Chandler 550
San Jose 534
Jacksonville 403
Ashburn 359
Dublin 356
Beijing 224
Dallas 186
Princeton 176
Los Angeles 162
Santa Clara 158
Izmir 153
Nanjing 139
Ho Chi Minh City 111
Altamura 93
Dearborn 89
The Dalles 78
Cambridge 72
Hanoi 72
Boardman 70
Pescara 70
Ann Arbor 68
Wilmington 64
Hong Kong 60
Nanchang 56
New York 52
Redondo Beach 39
Moscow 38
Chieti 37
São Paulo 37
Tongling 37
Woodbridge 36
Buffalo 35
Milan 35
Council Bluffs 34
Washington 33
Hefei 32
Hebei 29
Orem 26
Chicago 24
Rome 23
Warsaw 23
Kunming 22
Mexico City 22
Brooklyn 21
Montreal 21
Seattle 21
Tianjin 21
Shenyang 20
Tokyo 20
Munich 19
Norwalk 19
Frankfurt am Main 17
Mumbai 17
Houston 16
Lappeenranta 16
Romola 16
Chennai 14
Denver 14
Jiaxing 14
London 14
Phoenix 14
San Francisco 14
Atlanta 13
Helsinki 13
Johannesburg 13
Nuremberg 13
Shanghai 13
Boston 12
Brussels 12
Dong Ket 12
Hangzhou 12
Manchester 12
Seoul 12
Haiphong 11
Rio de Janeiro 11
Amsterdam 10
Belo Horizonte 10
Stockholm 10
Tashkent 9
Ascoli Piceno 8
Da Nang 8
Istanbul 8
Kocaeli 8
Toronto 8
Vienna 8
Biên Hòa 7
Changsha 7
Dhaka 7
Ha Long 7
Hải Dương 7
Islamabad 7
Mordano 7
Bologna 6
Can Tho 6
Changchun 6
Düsseldorf 6
Jinan 6
L'aquila 6
Lanzhou 6
Totale 6.831
Nome #
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders. 172
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy 163
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 163
beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction. 148
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 140
T lymphocyte transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparison of four different infection protocols. 139
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo 139
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α 138
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 138
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 137
5-Azacytidine prevents transgene methylation in vivo 131
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation 129
"Designed" grafts for HLA-haploidentical stem cell transplantation 129
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion 127
Minimum information about T regulatory cells: A step toward reproducibility and standardization 126
Primary eyelid plasmacytoma 125
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation 124
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 123
To breathe or not to breathe: The haematopoietic stem/progenitor cells dilemma 119
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 119
G-CSF-induced thrombocytopenia in a healthy donor 118
MtDNA mutation associated with mitochondrial dysfunction in megakaryoblastic leukaemic cells 118
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major 117
Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells 116
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 116
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL 115
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation 115
Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector 114
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 113
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 113
The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells 113
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 113
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 112
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study 112
Interleukin 7-engineered stromal cells: A new approach for hastening naive T cell recruitment 112
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: Implications for cellular-based therapy 112
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 111
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 111
NeoR-based transduced T lymphocytes detected by real-time quantitative polymerase chain reaction 110
Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis [1] 109
Myelofibrosis and allogeneic transplantation: critical points and challenges 108
T regulatory cell separation for clinical application 108
Tregs: Hype or hope for allogeneic hematopoietic stem cell transplantation? 108
Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and enhanced green fluorescence protein genes in primary T lymphocytes 108
NOTCH and graft-versus-host disease 108
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia 107
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 107
Next generation HLA-haploidentical HSCT 107
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. 106
Mesenchymal cells recruit and regulate T regulatory cells 106
Chronic myeloproliferative disorders: The bone marrow stromal component is not involved in the malignant clone [13] 106
Interleukin-7-Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population 106
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 105
A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia 105
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 105
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 104
Hematopoietic stem/progenitor cells express myoglobin and neuroglobin: Adaptation to hypoxia or prevention from oxidative stress? 104
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 104
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 103
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells 103
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation 103
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma 103
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 103
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 102
Mesenchymal cells: A vehicle for gene therapy 101
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production 101
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity 99
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 99
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 98
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL 97
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option 97
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 97
Graft engineering for allogeneic haploidentical stem cell transplantation 97
NOTCH1 aberrations in Chronic lymphocytic leukemia 97
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 96
Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy 96
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 96
A new genetic lesion in B-CLL: A NOTCH1 PEST domain mutation 95
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party 92
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma 92
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation 92
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 91
Immunomagnetic isolation of CD4+CD25+FoxP3 + natural T regulatory lymphocytes for clinical applications 91
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders [6] 90
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial 89
NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells 89
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation 88
Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines 87
Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag 85
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics 84
Allogeneic stem cell transplantation in multiple myeloma: is there still a place? 84
Large-scale generation of human allodepleted anti-3rd party lymphocytes 80
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 80
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 79
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: De-novo origin? 78
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 77
Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis 76
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation 76
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 75
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 74
Totale 10.743
Categoria #
all - tutte 43.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 26 2 94
2021/2022409 2 9 18 40 37 9 7 33 33 40 39 142
2022/20231.476 120 195 85 188 171 269 74 117 156 17 43 41
2023/2024698 54 23 60 29 67 155 153 36 22 45 10 44
2024/20252.302 121 542 502 86 44 79 102 122 182 80 243 199
2025/20264.132 386 227 437 432 468 305 855 285 461 276 0 0
Totale 11.564